Serum concentration of matrix metalloproteinases and angiogenic factors in patients with venous leg ulcers

被引:0
作者
Kolano, Pawel [1 ]
Bednarski, Igor A. [2 ]
Kraska-Gacka, Marzena [3 ]
Narbutt, Joanna [2 ]
Lesiak, Aleksandra [2 ]
机构
[1] Tomaszow Hlth Ctr, Dept Gen & Oncol Surg, Tomaszow Mazowiecki, Poland
[2] Med Univ Lodz, Dermatol Pediat Dermatol & Oncol Clin, 1-5 Kniaziewicza St, PL-91347 Lodz, Poland
[3] Med Univ Lodz, Dept Dermatol & Venereol, Lodz, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2021年 / 38卷 / 02期
关键词
venous leg ulcers; cathepsin K; ENDOTHELIAL GROWTH-FACTOR; POOR-PROGNOSIS; DISEASE; VEGF;
D O I
10.5114/ada.2021.106201
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Leg ulcers are a frequently observed medical problem affecting 3-5% of the general population over 65 years of age. The most common factor responsible for the development of leg ulcers is chronic venous insufficiency (CVI). It is believed that during the formation of an ulcer there are two processes occurring simultaneously, extracellular matrix (ECM) degradation and angiogenesis in which several proteins including matrix metalloproteinases, angiogenic and regulatory factors are engaged. Aim: To determine the serum concentration of matrix metalloproteinase-1 (MMP-1), -9 (MMP-9), tissue inhibitors of metalloproteinases-1 (TIMP-1), angiogenin and vascular endothelial growth factor (VEGF) in patients suffering from venous leg ulcers and in the healthy control group. Material and methods: The study group consisted of 71 Caucasians (39 patients, 32 controls). To evaluate the serum concentration of MMP-1, MMP-9, TIMP-1, VEGF and angiogenin, the ELISA technique was used. Results: Mean MMP-1 and MMP-9 concentrations in the study group were 14.16 +/- 2.98 and 12.45 +/- 3.85 ng/ml, respectively, and in controls 6.08 +/- 2.51 ng/ml and 6.77 +/- 2.41 ng/ml, respectively and both differences were statistically significant (p < 0.001). There was no significant difference between the study and the control group in TIMP-1 concentration. Mean VEGF and ANG concentrations in the study group were 589.3 +/- 346.2 pg/ml and 1802.0 +/- 415.7 pg/ml, respectively, and in controls 220.3 +/- 110.4 pg/ml and 1229.0 +/- 337.7 pg/ml, respectively and both differences were statistically significant (p < 0.001). Conclusions: Lack of significant differences in the concentration of TIMP-1 between the control and the study group confirms that proteolysis is a hallmark of CVI, but increased concentration of VEGF and angiogenin in the study group compared to the control group shows that angiogenesis occurs simultaneously with ECM remodelling.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 38 条
  • [1] Role of matrix metalloproteinases in non-healing venous ulcers
    Amato, Bruno
    Coretti, Guido
    Compagna, Rita
    Amato, Maurizio
    Buffone, Gianluca
    Gigliotti, Diego
    Grande, Raffaele
    Serra, Raffaele
    de Franciscis, Stefano
    [J]. INTERNATIONAL WOUND JOURNAL, 2015, 12 (06) : 641 - 645
  • [2] VEGF-B is a potent antioxidant
    Arjunan, Pachiappan
    Lin, Xianchai
    Tang, Zhongshu
    Du, Yuxiang
    Kumar, Anil
    Liu, Lixian
    Yin, Xiangke
    Huang, Lijuan
    Chen, Wei
    Chen, Qishan
    Ye, Zhimin
    Wang, Shasha
    Kuang, Haiqing
    Zhou, Linbin
    Xu, Kai
    Chen, Xue
    Zeng, Haitao
    Lu, Weisi
    Cao, Yihai
    Liu, Yizhi
    Zhao, Chen
    Li, Xuri
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (41) : 10351 - 10356
  • [3] Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology
    Banks, RE
    Forbes, MA
    Kinsey, SE
    Stanley, A
    Ingham, E
    Walters, C
    Selby, PJ
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 956 - 964
  • [4] The Role of Vascular Endothelial Growth Factor in Wound Healing
    Bao, Philip
    Kodra, Arber
    Tomic-Canic, Marjana
    Golinko, Michael S.
    Ehrlich, H. Paul
    Brem, Harold
    [J]. JOURNAL OF SURGICAL RESEARCH, 2009, 153 (02) : 347 - 358
  • [5] Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke
    Berntsson, John
    Smith, J. Gustav
    Johnson, Linda S. B.
    Soderholm, Martin
    Borne, Yan
    Melander, Olle
    Orho-Melander, Marju
    Nilsson, Jan
    Engstrom, Gunnar
    [J]. HEART, 2019, 105 (07) : 553 - 558
  • [6] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS
    BERSE, B
    BROWN, LF
    VANDEWATER, L
    DVORAK, HF
    SENGER, DR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220
  • [7] The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
    Brew, Keith
    Nagase, Hideaki
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (01): : 55 - 71
  • [8] Metalloproteinases and Wound Healing
    Caley, Matthew P.
    Martins, Vera L. C.
    O'Toole, Edel A.
    [J]. ADVANCES IN WOUND CARE, 2015, 4 (04) : 225 - 234
  • [9] The regulation of matrix metalloproteinases and their inhibitors
    Clark, Ian A.
    Swingler, Tracey E.
    Sampieri, Clara L.
    Edwards, Dylan R.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7) : 1362 - 1378
  • [10] Curylo M., 2017, J ED HLTH SPORT, V7, P49, DOI [10.5281/zenodo.858684, DOI 10.5281/ZENODO.858684]